APA
Lo H. Y., Nemoto P. A., Kim J. M., Hao M., Qian K. C., Farrow N. A., Albaugh D. R., Fowler D. M., Schneiderman R. D., Michael August E., Martin L., Hill-Drzewi M., Pullen S. S., Takahashi H. & De Lombaert S. (20111122). Benzimidazolone as potent chymase inhibitor: modulation of reactive metabolite formation in the hydrophobic (P1) region. : Bioorganic & medicinal chemistry letters.
Chicago
Lo Ho Yin, Nemoto Peter A, Kim Jin Mi, Hao Ming-Hong, Qian Kevin C, Farrow Neil A, Albaugh Daniel R, Fowler Danielle M, Schneiderman Richard D, Michael August E, Martin Leslie, Hill-Drzewi Melissa, Pullen Steven S, Takahashi Hidenori and De Lombaert Stéphane. 20111122. Benzimidazolone as potent chymase inhibitor: modulation of reactive metabolite formation in the hydrophobic (P1) region. : Bioorganic & medicinal chemistry letters.
Harvard
Lo H. Y., Nemoto P. A., Kim J. M., Hao M., Qian K. C., Farrow N. A., Albaugh D. R., Fowler D. M., Schneiderman R. D., Michael August E., Martin L., Hill-Drzewi M., Pullen S. S., Takahashi H. and De Lombaert S. (20111122). Benzimidazolone as potent chymase inhibitor: modulation of reactive metabolite formation in the hydrophobic (P1) region. : Bioorganic & medicinal chemistry letters.
MLA
Lo Ho Yin, Nemoto Peter A, Kim Jin Mi, Hao Ming-Hong, Qian Kevin C, Farrow Neil A, Albaugh Daniel R, Fowler Danielle M, Schneiderman Richard D, Michael August E, Martin Leslie, Hill-Drzewi Melissa, Pullen Steven S, Takahashi Hidenori and De Lombaert Stéphane. Benzimidazolone as potent chymase inhibitor: modulation of reactive metabolite formation in the hydrophobic (P1) region. : Bioorganic & medicinal chemistry letters. 20111122.